Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See More
Dear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
See MoreDear Customer, If you experience any text readability or display issues on our website, please update your web browser to the latest version
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Flow cytometric analysis of CD199 (CCR9) expressed on MOLT-4 cells. Human MOLT-4 cells were stained with either PE Mouse anti-Human CD199 (CCR9) antibody (Cat. No. 561607, solid line histogram) or a PE mIgG2a, κ Isotype Control (Cat. No. 553457; dashed line histogram). Flow cytometric fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry was performed using a BD LSR™ II Flow Cytometer System.
Flow cytometric analysis of CD199 (CCR9) expressed on MOLT-4 cells. Human MOLT-4 cells were stained with either PE Mouse anti-Human CD199 (CCR9) antibody (Cat. No. 561607, solid line histogram) or a PE mIgG2a, κ Isotype Control (Cat. No. 553457; dashed line histogram). Flow cytometric fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry was performed using a BD LSR™ II Flow Cytometer System.
Flow cytometric analysis of CD199 (CCR9) expressed on MOLT-4 cells. Human MOLT-4 cells were stained with either PE Mouse anti-Human CD199 (CCR9) antibody (Cat. No. 561607, solid line histogram) or a PE mIgG2a, κ Isotype Control (Cat. No. 553457; dashed line histogram). Flow cytometric fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of viable cells. Flow cytometry was performed using a BD LSR™ II Flow Cytometer System.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
The 112509 monoclonal antibody specifically binds to the human CCR9 chemokine receptor. CCR9 is a thymus specific CC chemokine receptor expressed at high levels by essentially all CD4+ and CD8+ T lymphocytes. CCR9 and its ligand CCL25/TECK are involved in lymphocyte recruitment in the small intestine. The immunogen used to generate the 112509 hybridoma was human CCR9-transfected cells.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.